BEBT-706

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameBEBT-706
Drug Alias NameBEBT-706BEBT706
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionApolipoprotein(a) inhibitorsProprotein convertase subtilisin kexin type 9 inhibitors
TargetsApolipoprotein(a)Proprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou BeBetter Medicine Technology Co
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou BeBetter Medicine Technology Co
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A